Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain

Zeiler E, Gabriel S, Ncube M, Thompson N, Newmire D, Scharf E, et al
Simple timing framework Baseline Discuss baseline labs before starting or changing dose, especially with diabetes, kidney disease, pancreatitis history, gallbladder history, thyroid cancer history, or major calorie restriction
Oral Supplements Both forms are available and may be appropriate for different patients: Absorption rate: Oral L-Carnitine must pass through the digestive system before absorption
Why the Comparison is Still Incomplete This is the part many summary articles skip: no direct randomized head-to-head trial is currently available in the published literature comparing retatrutide with tirzepatide on the same protocol, in the same population, over the same duration